Injection Site Reactions The most frequently reported aod 9604 peptide side effects involve local reactions at injection sites
Pain or swelling at the injection site, itchiness, or diarrhea can occur
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
Unlike GLP-1 peptides like semaglutide , which frequently cause significant nausea as part of their mechanism of action, AOD 9604 does not suppress appetite or slow gastric emptying
Yes, injections are more effective for people who cannot absorb B12 properly, as they bypass the digestive system and deliver the vitamin directly into the bloodstream
